Benchmark indices open on a negative note with Nifty Media among the top losers!
Benchmark indices open on a negative note with Nifty Media among the top losers!

Benchmark indices open on a negative note with Nifty Media among the top losers!

On Friday, Indian markets opened on a negative note, with both Nifty and Sensex showing negative movement.

Siddharth Mane Article rating: 5.0

On October 17, 2024, foreign institutional investors (FII) sold shares worth Rs 7,421.40 crore, while domestic institutional investors (DII) bought shares worth Rs 4,979.83 crore.

Top things you must know before the market opens!
Top things you must know before the market opens!

Top things you must know before the market opens!

The GIFT Nifty is trading slightly higher, suggesting a flat to mildly positive opening for the markets. Nifty futures are currently at 24,794.

Siddharth Mane Article rating: 4.0

On December 5, 2024, foreign institutional investors (FII) bought shares worth Rs 8,539.91 crore, while domestic institutional investors (DII) sold shares worth Rs 2,303.64 crore.

Battery manufacturer invested Rs 99,99,99,972 by way of subscription in the equity share capital of its wholly owned subsidiary on rights basis
Battery manufacturer invested Rs 99,99,99,972 by way of subscription in the equity share capital of its wholly owned subsidiary on rights basis

Battery manufacturer invested Rs 99,99,99,972 by way of subscription in the equity share capital of its wholly owned subsidiary on rights basis

Battery Manufacturer Invests Rs. 99.99 Crore in Wholly Owned Subsidiary EESL

Pushkar Shinde Article rating: 5.0

Battery Manufacturer Invests Rs. 99.99 Crore in Wholly Owned Subsidiary EESL

Stock Under Rs 100 Sees 3,728 per cent Sales Growth in 3 Years, Now Launches Stationery Brand
Stock Under Rs 100 Sees 3,728 per cent Sales Growth in 3 Years, Now Launches Stationery Brand

Stock Under Rs 100 Sees 3,728 per cent Sales Growth in 3 Years, Now Launches Stationery Brand

With a remarkable 3,728% sales growth in just 3 years, the stock under Rs 100 diversifies its portfolio by entering the stationery market with an innovative new brand.

Pushkar Shinde Article rating: 3.3

With a remarkable 3,728% sales growth in just 3 years, the stock under Rs 100 diversifies its portfolio by entering the stationery market with an innovative new brand.

Indian Pharma Company Scores Major USFDA Approval for Game-Changing Capsule, Plans 5+ New Product Launches!
Indian Pharma Company Scores Major USFDA Approval for Game-Changing Capsule, Plans 5+ New Product Launches!

Indian Pharma Company Scores Major USFDA Approval for Game-Changing Capsule, Plans 5+ New Product Launches!

With the USFDA's green light, the Indian pharmaceutical company is poised to expand its product portfolio and strengthen its global presence

Pushkar Shinde Article rating: 5.0

With the USFDA's green light, the Indian pharmaceutical company is poised to expand its product portfolio and strengthen its global presence

RSS
1345678910Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR